BioRestorative Therapies (NASDAQ:BRTX) just reported results for the second quarter of 2024.
- BioRestorative Therapies reported earnings per share of -50 cents. This was above the analyst estimate for EPS of -56 cents.
- The company reported revenue of $89,100.
- This was 791% better than the analyst estimate for revenue of $10,000.